198 related articles for article (PubMed ID: 11175333)
1. Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression.
Okamoto T; Izumi H; Imamura T; Takano H; Ise T; Uchiumi T; Kuwano M; Kohno K
Oncogene; 2000 Dec; 19(54):6194-202. PubMed ID: 11175333
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the 5'-untranslated region of YB-1 mRNA and autoregulation of translation by YB-1 protein.
Fukuda T; Ashizuka M; Nakamura T; Shibahara K; Maeda K; Izumi H; Kohno K; Kuwano M; Uchiumi T
Nucleic Acids Res; 2004; 32(2):611-22. PubMed ID: 14752049
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen.
Ise T; Nagatani G; Imamura T; Kato K; Takano H; Nomoto M; Izumi H; Ohmori H; Okamoto T; Ohga T; Uchiumi T; Kuwano M; Kohno K
Cancer Res; 1999 Jan; 59(2):342-6. PubMed ID: 9927044
[TBL] [Abstract][Full Text] [Related]
4. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light.
Ohga T; Koike K; Ono M; Makino Y; Itagaki Y; Tanimoto M; Kuwano M; Kohno K
Cancer Res; 1996 Sep; 56(18):4224-8. PubMed ID: 8797596
[TBL] [Abstract][Full Text] [Related]
5. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.
Yoshimatsu T; Uramoto H; Oyama T; Yashima Y; Gu C; Morita M; Sugio K; Kohno K; Yasumoto K
Anticancer Res; 2005; 25(5):3437-43. PubMed ID: 16101161
[TBL] [Abstract][Full Text] [Related]
6. Nuclear localization of Y-box factor YB1 requires wild-type p53.
Zhang YF; Homer C; Edwards SJ; Hananeia L; Lasham A; Royds J; Sheard P; Braithwaite AW
Oncogene; 2003 May; 22(18):2782-94. PubMed ID: 12743601
[TBL] [Abstract][Full Text] [Related]
7. Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIalpha and proliferating cell nuclear antigen expression in lung cancer.
Gu C; Oyama T; Osaki T; Kohno K; Yasumoto K
Anticancer Res; 2001; 21(4A):2357-62. PubMed ID: 11724293
[TBL] [Abstract][Full Text] [Related]
8. The solution structure and DNA-binding properties of the cold-shock domain of the human Y-box protein YB-1.
Kloks CP; Spronk CA; Lasonder E; Hoffmann A; Vuister GW; Grzesiek S; Hilbers CW
J Mol Biol; 2002 Feb; 316(2):317-26. PubMed ID: 11851341
[TBL] [Abstract][Full Text] [Related]
9. The pleiotropic functions of the Y-box-binding protein, YB-1.
Kohno K; Izumi H; Uchiumi T; Ashizuka M; Kuwano M
Bioessays; 2003 Jul; 25(7):691-8. PubMed ID: 12815724
[TBL] [Abstract][Full Text] [Related]
10. Involvement of a DNA binding protein, MDR-NF1/YB-1, in human MDR1 gene expression by actinomycin D.
Asakuno K; Kohno K; Uchiumi T; Kubo T; Sato S; Isono M; Kuwano M
Biochem Biophys Res Commun; 1994 Mar; 199(3):1428-35. PubMed ID: 7908518
[TBL] [Abstract][Full Text] [Related]
11. The UV responsive elements in the human mimecan promoter: a functional characterization.
Tasheva ES; Conrad GW
Mol Vis; 2003 Jan; 9():1-9. PubMed ID: 12533723
[TBL] [Abstract][Full Text] [Related]
12. Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage.
Jin S; Fan F; Fan W; Zhao H; Tong T; Blanck P; Alomo I; Rajasekaran B; Zhan Q
Oncogene; 2001 May; 20(21):2683-90. PubMed ID: 11420680
[TBL] [Abstract][Full Text] [Related]
13. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
Tian B; Liu J; Liu B; Dong Y; Liu J; Song Y; Sun Z
J Cell Physiol; 2011 Dec; 226(12):3433-41. PubMed ID: 21344396
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the MAP kinase pathways in induction of GADD45 following UV radiation.
Tong T; Fan W; Zhao H; Jin S; Fan F; Blanck P; Alomo I; Rajasekaran B; Liu Y; Holbrook NJ; Zhan Q
Exp Cell Res; 2001 Sep; 269(1):64-72. PubMed ID: 11525640
[TBL] [Abstract][Full Text] [Related]
15. p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y.
Faniello MC; Di Sanzo M; Quaresima B; Baudi F; Di Caro V; Cuda G; Morrone G; Del Sal G; Spinelli G; Venuta S; Costanzo F
Int J Biochem Cell Biol; 2008; 40(10):2110-9. PubMed ID: 18372207
[TBL] [Abstract][Full Text] [Related]
16. Functional interaction between p53 and the interferon-inducible nucleoprotein IFI 16.
Johnstone RW; Wei W; Greenway A; Trapani JA
Oncogene; 2000 Dec; 19(52):6033-42. PubMed ID: 11146555
[TBL] [Abstract][Full Text] [Related]
17. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
19. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
[TBL] [Abstract][Full Text] [Related]
20. Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells.
Berquin IM; Pang B; Dziubinski ML; Scott LM; Chen YQ; Nolan GP; Ethier SP
Oncogene; 2005 Apr; 24(19):3177-86. PubMed ID: 15735691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]